‘Big Pharma’ is often criticised on a number of levels but...

‘Big Pharma’ is often criticised on a number of levels but ...

mid-size Acadia appears to be the ‘good citizen’ ... nice to see

Today I was offered a new short course by myCME, which is a provider of free continuing medical education. I was particularly interested because of another ASX share I am heavily invested in. Now, this course was looking at Parkinson disease psychosis (PDP) which is a huge issue in this terrible condition. On skimming the synopsis, I noticed that the course was sponsored by NEU’s partner, Acadia Pharmaceuticals.

For this I must congratulate Acadiaon doing way more than just sales by ‘giving back’ to the wider medical community, via these free courses. A good medical citizen if you like.

So, I explored further, and found that they were spreading the word about new Rett treatments (this should surprise you). I’m sure you can guess that the wonderful Daybue is ‘front and centre’.

So, it’s all above board when you offer help (training), while you ‘highlight’ your own treatment. Everyone ‘wins’ really.

Note the synopsis given for the Rett course ...